Saudi Ministry of Health

Riyadh, Saudi Arabia

Saudi Ministry of Health

Riyadh, Saudi Arabia
SEARCH FILTERS
Time filter
Source Type

Organized by the Saudi Ministry of Health, the U.S.-Saudi Arabian Business Council (USSABC), and the Ministry of Commerce and Investment, and held in collaboration with GE (NYSE: GE), the conference is designed to provide a platform to senior business executives and government representatives, from both countries, to review specific commercial and investment opportunities and network with potential business partners. Specifically, the event will introduce U.S. healthcare manufacturers and service providers to opportunities in Saudi Arabia for sales, technical tie-ups, joint ventures and investments in Saudi Arabia's expanding healthcare market. The program will feature panel discussions with U.S. and Saudi company executives who are already successfully engaged in the Saudi market alongside Saudi Government experts from a wide variety of fields, and will present ample networking opportunities. H.E. Dr. Tawfig AlRabiah, Saudi Minister of Health, said: "Saudi Vision 2030 has given us a driving force to move forward with solid steps regarding the reforms needed to uplift the level of healthcare in the Kingdom. Key to these reforms are public private partnerships and global best practices. We are reaching out to foreign investors in this vital sector, and want to spearhead this initiative by coming into contact with as many key players as possible from the United States." H.E. Dr. Majid AlKassabi, Saudi Minister of Commerce & Investment added: "As a part of Vision 2030, the Kingdom is seeking to form and encourage partnerships with firms to raise the competitiveness and productivity across the healthcare industry. The Saudi Horizons Healthcare Conference will bring together the American and Saudi public and private sectors to explore Saudi Arabia's rapidly expanding and re-structuring healthcare market. These changes are creating lucrative and exciting opportunities for local and foreign investors alike." Emphasizing the importance of the event, Edward Burton, USSABC President and CEO said, "This is a unique opportunity to inform the American business community in the healthcare industry about the unprecedented market growth opportunities in this critically important sector within the Kingdom of Saudi Arabia. It will also provide unequaled access to the key government and private sector decision makers who are having high developmental impact on the direction of this industry." Confirmed Saudi high-level officials and executives to address the conference include H.E. Dr. Tawfig AlRabiah, Minister of Health; H.E. Dr. Majid AlKassabi, Minister of Commerce and Investment; H.E. Dr. Qasim Al Qasabi, CEO, King Faisal Specialist Hospital and Research Center; Dr. Hisham Al-Jadhey, CEO, Saudi Food and Drug Administration; Dr. Mahmoud Al-Yamany, CEO, King Fahad Medical City; and Fahad Al Rasheed, Managing Director and CEO, King Abdullah Economic City. Distinguished U.S. senior executives confirmed to speak at the conference include Mr. Jeffrey Immelt, Chairman and CEO, GE; Dr. Omar Ishrak, Chairman and CEO, Medtronic; Dr. Paul Rothman, CEO, Johns Hopkins Medicine; Dr. Marc Boom, President and CEO, Houston Methodist Hospital; and Mr. Dennis Kogod, CEO Emeritus, DaVita International. Saudi Arabia has allocated $32 billion for healthcare and social spending in its 2017 budget, an increase of nearly $5 billion over 2016 and a significantly larger budget than any other country in the Gulf Cooperation Council (GCC) region. In addition, demand for healthcare services in Saudi Arabia is projected to increase by 25 percent through 2025 with expenditure in the sector growing at an annual rate of 10 percent. Over the next five years, Saudi Arabia is expected to spend $180 billion on healthcare: an additional $100 billion on healthcare service provision, $54 billion on pharmaceuticals, and $14 billion on medical products. For media interested in attending and covering the Conference, please contact: Jay Ennis Director, Communications and Information Services U.S.-Saudi Arabian Business Council Tel.: 703-962-9300 Email: jennis@us-sabc.org The U.S.-Saudi Arabian Business Council (USSABC) was established in December 1993 to improve the mutual knowledge and understanding between the private sectors of the U.S and Saudi Arabia and to promote and facilitate increased trade and investment between the two countries. The USSABC has built a membership base of approximately 350 leading companies in the U.S. and Saudi Arabia and serves as the central source of information and assistance for companies that want to pursue specific business activities in Saudi Arabia.  The USSABC organizes conferences and seminars in both countries to promote dialogue between the two private sectors, as well as trade and investment missions that provide networking opportunities for U.S. and Saudi companies. For more information on the Business Council, please visit www.us-sabc.org. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/saudi-arabia-seeking-us-partners-unprecedented-partnership-opportunities-to-be-unveiled-at-saudi-healthcare-conference-in-boston-300440388.html


Al-Salem W.S.,Saudi Ministry of Health | Kelly-Hope L.,Center for Neglected Tropical Diseases | Abdeladhim M.,National Institute of Allergy and Infectious Diseases | Al-Zahrani M.H.,Saudi Ministry of Health | Valenzuela J.G.,National Institute of Allergy and Infectious Diseases
PLoS Neglected Tropical Diseases | Year: 2015

The sandfly Phlebotomus papatasi is the vector of Leishmania major, the main causative agent of Old World cutaneous leishmaniasis (CL) in Saudi Arabia. Sandflies inject saliva while feeding and the salivary protein PpSP32 was previously shown to be a biomarker for bite exposure. Here we used recombinant PpSP32 to evaluate human exposure to Ph. papatasi bites, and study the association between antibody response to saliva and CL in endemic areas in Saudi Arabia. In this observational study, anti-PpSP32 antibodies, as indicators of exposure to sandfly bites, were measured in sera from healthy individuals and patients from endemic regions in Saudi Arabia with active and cured CL. Ph. papatasi was identified as the primary CL vector in the study area. Anti-PpSP32 antibody levels were significantly higher in CL patients presenting active infections from all geographical regions compared to CL cured and healthy individuals. Furthermore, higher anti-PpSP32 antibody levels correlated with the prevalence and type of CL lesions (nodular vs. papular) observed in patients, especially non-local construction workers. Our findings suggest a possible correlation between the type of immunity generated by the exposure to sandfly bites and disease outcome.


Memish Z.A.,Ministry of Health | Assiri A.M.,Ministry of Health | Hussain R.,Virology Unit | Alomar I.,Administration of Laboratories and Blood Banks | Stephens G.,Saudi Ministry of Health
Journal of Travel Medicine | Year: 2012

Background. The objectives of this study were to determine whether pilgrim attendance at the Hajj was associated with an increased risk of acquiring influenza, and other respiratory viruses, and to evaluate the compliance of pilgrims with influenza vaccination and other recommended preventive measures. Methods. A cross-sectional survey was conducted among pilgrims as they arrived at the King Abdulaziz International Airport in Jeddah for the 2009 Hajj and as they departed from the same airport during the week after the Hajj. Nasopharyngeal and throat swabs were tested for 18 respiratory virus types and subtypes using the xTAG Respiratory Viral Panel FAST assay. Results. A total of 519 arriving pilgrims and 2,699 departing pilgrims were examined. Their mean age was 49 years and 58% were male. In all, 30% of pilgrims stated that they had received pandemic influenza A(H1N1) vaccine before leaving for the Hajj and 35% of arriving pilgrims reported wearing a face mask. Only 50% of arriving pilgrims were aware of preventive measures such as hand hygiene and wearing a mask. The prevalence of any respiratory-virus infection was 14.5% (12.5% among arriving pilgrims and 14.8% among departing pilgrims). The main viruses detected (both groups combined) were rhinovirus-enterovirus (N = 414, 12.9%), coronaviruses (N = 27, 0.8%), respiratory syncytial virus (N = 8, 0.2%), and influenza A virus (N = 8, 0.2%) including pandemic influenza A(H1N1) (N = 3, 0.1%). The prevalence of pandemic influenza A(H1N1) was 0.2% (N = 1) among arriving pilgrims and 0.1% (N = 2) among departing pilgrims. The prevalence of any respiratory virus infection was lower among those who said they received H1N1 vaccine compared to those who said they did not receive it (11.8% vs 15.6%, respectively, p = 0.009). Conclusion. We found very low pandemic influenza A(H1N1) prevalence among arriving pilgrims and no evidence that amplification of transmission had occurred among departing pilgrims. © 2011 International Society of Travel Medicine.


Yezli S.,Bioquell UK Ltd | Shibl A.M.,King Saud University | Livermore D.M.,University of East Anglia | Memish Z.A.,Saudi Ministry of Health
Journal of Chemotherapy | Year: 2012

Several species of Gram-positive cocci are major nosocomial or community pathogens associated with morbidity and mortality. Here, we review the antimicrobial resistance among these pathogens in Saudi Arabia. In the last decades, antimicrobial resistance has increased among Staphylococcus aureus in the Kingdom with a growing prevalence of both nosocomial and community methicillin resistant S. aureus (MRSA) isolates. As yet, no vancomycin-resistant MRSA have been reorted, although isolates with reduced susceptibility to the drug have been noted. Currently, the prevalence of vancomycin-resistant entrococci (VRE) is low; however, VRE has been described in the Kingdom as well as Enterococcus faecalis and E. faecium isolates with high-level resistance to penicillin, sulfamethoxazole, macrolides, tetracycline, and aminoglycosides. In recent decades, the prevalence and rate of penicillin resistance and non-susceptibility among Streptococcus pneumoniae isolates have increased in Saudi Arabia. The organism remains, however, susceptible to other beta-lactams and to quinolones. On the other hand, resistance to co-trimoxazole and tetracyclines is high and resistance to macrolides is on the increase. © 2012 Edizioni Scientifiche per l'Informazione su Farmaci e Terapia.


Yezli S.,Bioquell UK Ltd andover | Shibl A.M.,King Saud University | Livermore D.M.,University of East Anglia | Memish Z.A.,Saudi Ministry of Health
Journal of Chemotherapy | Year: 2014

Antimicrobial resistance among Gram-negative bacteria is a worldwide problem, including in the Kingdom of Saudi Arabia, with major concerns regarding Pseudomonas aeruginosa, Acinetobacter baumannii, and Enterobacteriaceae. Although over half of the isolates of P. aeruginosa remain susceptible to carbapenems, quinolones, and aminoglycosides in most reports from Saudi Arabia, resistance is on increase, with a worrying high prevalence of multidrug resistance. Ceftazidime, ciprofloxacin, and aminoglycosides remain active against A. baumannii isolates in some studies from the Kingdom, but recent data suggest increased resistance. Carbapenems are now the treatment of choice for Acinetobacter infections but their activity too is being eroded. Among Enterobacteriaceae, Escherichia coli, Klebsiella pneumoniae, and Enterobacter spp. are the most clinically relevant species. Rates of extended-spectrum beta-lactamase (ESBL) production by these species vary among studies but are generally high in Saudi Arabia, with many ESBL-producing isolates multiresistant to other agents, except carbapenems and nitrofurantoin. A similar pattern is seen for Klebsiella, although with more resistance to quinolones, aminoglycosides, and to nitrofurantoin than in E. coli. Enterobacter is commonly resistant to penicillins, monobactams, and cephalosporins but mostly susceptible to carbapenems. Carbapenemases are beginning to emerge in Enterobacteriaceae. © 2014 Edizioni Scientifiche per l’Informazione su Farmaci e Terapia.


Memish Z.A.,Saudi Ministry of Health | Charrel R.N.,Aix - Marseille University | Zaki A.M.,Doctor Soliman Fakeeh Hospital | Fagbo S.F.,Saudi Ministry of Health
International Journal of Antimicrobial Agents | Year: 2010

The emergence and re-emergence of human and animal pathogens on a global scale continues unabated. One such pathogen is the arbovirus that causes Alkhurma haemorrhagic fever, which emerged in the Kingdom of Saudi Arabia in the mid 1990s. It has since re-emerged in other regions of the country and threatens to widen its area of endemicity beyond the peninsula. Human and animal movements, especially those associated with the annual mass gathering event of Hajj (pilgrimage) may facilitate introduction into other continental masses, where it must be differentiated from dengue and other similar arboviral haemorrhagic fevers. In addition to dengue and Kadam viruses, which are known to be endemic in Saudi Arabia, it is thought that other flaviviruses exist in the region, though undetected. Collectively, these viruses present diagnostic challenges that may confound the recognition of clinical cases of Alkhurma haemorrhagic fever. The Saudi Ministry of Health is making concerted efforts to expand the evidence base in order to enhance the diagnostic and preventive protocols used to address the challenge of Alkhurma haemorrhagic fever. © 2010 Elsevier B.V. and the International Society of Chemotherapy.


Yezli S.,Saudi Ministry of Health | Shibl A.M.,King Saud University | Memish Z.A.,Saudi Ministry of Health | Memish Z.A.,Alfaisal University
Journal of Medical Microbiology | Year: 2015

Resistance to β-lactams among Gram-negative bacteria is a worldwide issue. Increased prevalence of extended-spectrum β-lactamase (ESBL)-producers and the dissemination of carbapenem-resistance genes are particularly concerning. ESBL-producing strains are common in the Kingdom of Saudi Arabia, particularly among the Enterobacteriaceae, and carbapenem resistance is on the increase, especially among the non-fermenters. β-lactamase production is a major mechanism of resistance to these agents and although β-lactamase-producing strains have been documented in the Kingdom, relatively few reports characterized the molecular basis of this production. Nevertheless, available data suggest that CTX-M (CTX-M-15 in particular) is the predominant ESBL in the Enterobacteriaceae, with SHV also being prevalent in Klebsiella pneumoniae. Carbapenem resistance in the latter is mainly due to OXA-48 and NDM-1. In Pseudomonas aeruginosa, VEB-like enzymes are the most common ESBLs, and VIM is the prevalent metallo-β-lactamase. OXA-10 extended-spectrum enzymes are also frequent. PER and GES ESBLs have been reported in Acinetobacter baumannii, and oxacillinases (OXA-23 in particular) are the dominant carbapanamases in this species. © 2015 The Authors.


Al-Tawfiq J.A.,Aramco Services Company | Abukhamsin A.,Aramco Services Company | Memish Z.A.,Saudi Ministry of Health
Travel Medicine and Infectious Disease | Year: 2013

Objective This study examines the epidemiology of varicella infection and the impact of vaccination in a population in Eastern Saudi Arabia. Methods All reported cases of varicella infection from 1994 to 2011 were analyzed. Results A total of 19,577 patients with varicella were reported during the study period, and 8869 were female and 10,248 were male, with a male to female ratio of 1.15:1. Most of the cases were reported in patients between one to four year of age (n = 5625; 29.4%) and five to nine years of age (n = 6614; 34.6%) years of age. The highest numbers of cases were reported in March-May corresponding to the spring time (39.3%) compared with 21.2% in the winter and 25.4% in the summer time. The childhood varicella vaccine was introduced in 1998 and was made mandatory in 2008. The total number of cases decreased from 10,070 in the pre-vaccination period to 1577 cases in the mandatory vaccination period. The incidence rate decreased from 739.8 in 1994 to 355.3 in 1998, to 88.1 in 2011 per 100,000 population (P < 0.0001). Patients less than one year of age constituted 8.3% of cases in 1994-1997 prior to vaccination, 5.4% in 1998-2008 during the initial vaccination phase and 3.4% during the mandatory vaccination period (P < 0.0001). Conclusion The introduction of varicella vaccine resulted in a significant reduction in the incidence rates between 1994 and 2011. © 2013 Elsevier Ltd. All rights reserved.


Walston S.L.,Oklahoma City University | Al-Omar B.A.,King Saud University | Al-Mutari F.A.,Saudi Ministry of Health
International Journal of Health Care Quality Assurance | Year: 2010

Purpose: The purpose of this paper is to describe three organizational dimensions that influence hospital patient safety climate, also showing and discussing differences between organizational types. Design/methodology/approach: Surveys were conducted in four types of Saudi Arabian hospitals. Resultant information was analyzed using factor analysis and multiple-regression. Findings: Management support, a proper reporting system and adequate resources were found to influence the hospital patient safety climate. Research limitations/implications: The cross-sectional hospital survey took place in a country that is radically redesigning its healthcare system. Major changes including hospital privatisation and healthcare insurance systems may have significant effects on hospital organizational climates. Originality/value: Improving a hospital's patient safety climate is critical for decreasing errors and providing optimal services. Although much patient safety research has been published, the organizational climate in non-Western countries has not been studied. The paper provides a unique Saudi Arabian hospital perspective and suggests that three dimensions influence the patient safety climate. Hospital managers are encouraged to improve these critical dimensions to positively develop their patient safety climate. © Emerald Group Publishing Limited.


Yezli S.,Bioquell UK Ltd andover | Memish Z.A.,Saudi Ministry of Health
Journal of Chemotherapy | Year: 2012

Tuberculosis is a serious contagious disease caused by Mycobacterium tuberculosis and is endemic in many countries. Over the past two decades, there has been an increase in the number of multidrugresistant TB and extensively drug-resistant TB cases around the world. As in many countries, TB is common in Saudi Arabia. The disease is particularly relevant in the Kingdom because of its population dynamics including a large number of resident expatriates mainly from TB endemic regions and the influx of millions of pilgrims to the country each year during the Hajj and Umrah seasons. This review investigates the prevalence and antimicrobial resistance among M. tuberculosis isolates from Saudi Arabia, highlighting the variations in rates in different geographical areas with particularly high rates in the main cities and regions hosting the annual pilgrimage. The review also refers to the measures needed to prevent and control TB transmission in the country. © 2012 Edizioni Scientifiche per l'Informazione su Farmaci e Terapia.

Loading Saudi Ministry of Health collaborators
Loading Saudi Ministry of Health collaborators